The FDA approved B. Braun Medical Inc.’s application for 1g and 2g Ceftazidime for Inj and Dextrose Inj in the DUPLEX Drug Delivery System, a ready-to-use two-compartment, IV container that stores pre-measured drug and diluent doses. Healthcare workers administering Ceftazidime through DUPLEX can fold and squeeze the container then shake it to mix the drug and diluent. 0
Ceftazidime (Fortaz; GlaxoSmithKline and Tazicef; Hospira) is a cephalosporin antibiotic indicated to treat susceptible infections including septicemia, pneumonia, skin/skin structure, bone and joint, gynecologic, intra-abdominal, meningitis and urinary tract infections.
For more information call (888) 422-7286.